CMPX · NASDAQ
Compass Therapeutics (CMPX) Stock Price & Fundamentals
Compass Therapeutics (CMPX) closed at $590.80 on Oct 9, 2026, up 0.79% from the previous close of $586.17.
Share price, past year
1Y +14.93%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $590.80 |
| Sep 30, 2026 | $584.95 |
| Aug 31, 2026 | $599.31 |
| Jul 31, 2026 | $604.20 |
| Jun 30, 2026 | $610.55 |
| May 29, 2026 | $581.49 |
| Apr 30, 2026 | $574.86 |
| Mar 31, 2026 | $597.96 |
| Feb 27, 2026 | $583.65 |
| Jan 30, 2026 | $577.64 |
| Dec 31, 2025 | $541.57 |
| Nov 28, 2025 | $500.27 |
| Oct 31, 2025 | $512.14 |
Key statistics
- Market cap
- $106.40B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- −$73.45M
- Shares outstanding
- 180.1M
- Dividend yield
- —
- 52-week range
- $491.68 – $627.94
Compass Therapeutics's market cap is $106.40B, based on a share price of $590.80 and 180.1M shares outstanding as of Jun 30, 2026.
Financials
Compass Therapeutics reported revenue of $0.00 for fiscal 2025, down 100.00% from fiscal 2024.
Compass Therapeutics reported a net loss of $66.49M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $0.00 | −100.0% | −$66.49M | — | — | −$49.17M |
| FY2024ended Dec 31, 2024 | $850.00K | — | −$49.38M | −5,808.8% | — | −$44.90M |
| FY2023ended Dec 31, 2023 | $0.00 | — | −$42.49M | — | — | −$40.65M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q3 FY2025ended Sep 30, 2025 | $0.00 | −$14.26M | — |
| Q2 FY2025ended Jun 30, 2025 | $0.00 | −$19.88M | — |
| Q3 FY2024ended Sep 30, 2024 | $0.00 | −$10.48M | — |
| Q2 FY2024ended Jun 30, 2024 | $850.00K | — | — |
| Q3 FY2023ended Sep 30, 2023 | $0.00 | — | — |
| Q2 FY2023ended Jun 30, 2023 | $0.00 | — | — |
Company profile
- Name
- Compass Therapeutics, Inc.
- Ticker
- CMPX
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Biological Products, (No Diagnostic Substances)
- Headquarters
- 80 Guest Street, Boston, MA 02135
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001738021
Recent SEC filings
- Sep 22, 2026
- Aug 6, 2026
- Aug 6, 2026
- Jul 1, 2026
- Jun 23, 2026
- Jun 11, 2026
- May 5, 2026
- May 5, 2026
Frequently asked questions
What is Compass Therapeutics's stock price?
Compass Therapeutics (CMPX) closed at $590.80 on Oct 9, 2026, up 0.79% from the previous close of $586.17.
What is Compass Therapeutics's market cap?
Compass Therapeutics's market cap is $106.40B, based on a share price of $590.80 and 180.1M shares outstanding as of Jun 30, 2026.
How much revenue does Compass Therapeutics make?
Compass Therapeutics reported revenue of $0.00 for fiscal 2025, down 100.00% from fiscal 2024.
Does Compass Therapeutics pay a dividend?
Compass Therapeutics's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Compass Therapeutics, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures